The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy
Open accessAbstract
Central serous chorioretinopathy (CSCR) is a vision-threatening eye disease with no validated treatment and unknown pathogeny. In CSCR, dilation and leakage of choroid vessels underneath the retina cause subretinal fluid accumulation and retinal detachment. Because glucocorticoids induce and aggravate CSCR and are known to bind to the mineralocorticoid receptor (MR), CSCR may be related to inappropriate MR activation. Our aim was to assess the effect of MR activation on rat choroidal vasculature and translate the results to CSCR patients. Intravitreous injection of the glucocorticoid corticosterone in rat eyes induced choroidal enlargement. Aldosterone, a specific MR activator, elicited the same effect, producing choroid vessel dilation -and leakage. We identified an underlying mechanism of this effect: aldosterone upregulated the endothelial vasodilatory K channel KCa2.3. Its blockade prevented aldosterone-induced thickening. To translate these findings, we treated 2 patients with chronic nonresolved CSCR with oral eplerenone, a specific MR antagonist, for 5 weeks, and observed impressive and rapid resolution of retinal detachment and choroidal vasodilation as well as improved visual acuity. The benefit was maintained 5 months after eplerenone withdrawal. Our results identify MR signaling as a pathway controlling choroidal vascular bed relaxation and provide a pathogenic link with human CSCR, which suggests that blockade of MR could be used therapeutically to reverse choroid vasculopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enhanced Depth Imaging Spectral-Domain Optical Coherence Tomography
Spaide, R. F., Koizumi, H., & Pozonni, M. C. (2008) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2008.05.032 · Cited by 2,180
IMAMURA, Y., FUJIWARA, T., MARGOLIS, R., & SPAIDE, R. F. (2009) · Retina · doi:10.1097/iae.0b013e3181be0a83 · Cited by 955
11β-Hydroxysteroid Dehydrogenase and the Syndrome of Apparent Mineralocorticoid Excess*
White, P. C., Mune, T., & Agarwal, A. K. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0288 · Cited by 517
Risk factors for central serous chorioretinopathy
Haimovici, R., Koh, S., Gagnon, D. R., Lehrfeld, T., & Wellik, S. (2004) · Ophthalmology · doi:10.1016/j.ophtha.2003.09.024 · Cited by 475
Endothelium-derived hyperpolarising factors and associated pathways: a synopsis
Edwards, G., Félétou, M., & Weston, A. H. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0817-1 · Cited by 359
Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity
Leopold, J. A., Dam, A., Maron, B. A., Scribner, A. W., Liao, R., Handy, D. E., Stanton, R. C., Pitt, B., & Loscalzo, J. (2007) · Nature Medicine · doi:10.1038/nm1545 · Cited by 346
Central serous chorioretinopathy: an update on pathogenesis and treatment
Gemenetzi, M., De Salvo, G., & Lotery, A. J. (2010) · Eye · doi:10.1038/eye.2010.130 · Cited by 325
SUBFOVEAL CHOROIDAL THICKNESS IN FELLOW EYES OF PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY
Maruko, I., Iida, T., Sugano, Y., Ojima, A., & Sekiryu, T. (2011) · Retina · doi:10.1097/iae.0b013e31820f4b39 · Cited by 319
The Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological Biology
Viengchareun, S., Le Menuet, D., Martinerie, L., Munier, M., Tallec, L. P.-L., & Lombès, M. (2007) · Nuclear Receptor Signaling · doi:10.1621/nrs.05012 · Cited by 316
Central Serous Chorioretinopathy and Glucocorticoids
Bouzas, E. A., Karadimas, P., & Pournaras, C. J. (2002) · Survey of Ophthalmology · doi:10.1016/s0039-6257(02)00338-7 · Cited by 315
Cited by
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.003 · Cited by 989
Self-citationMechanisms of macular edema: Beyond the surface
Daruich, A., Matet, A., Moulin, A., Kowalczuk, L., Nicolas, M., Sellam, A., Rothschild, P.-R., Omri, S., Gélizé, E., Jonet, L., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.006 · Cited by 708
Self-citationCentral serous chorioretinopathy: Towards an evidence-based treatment guideline
van Rijssen, T. J., van Dijk, E. H. C., Yzer, S., Ohno-Matsui, K., Keunen, J. E. E., Schlingemann, R. O., Sivaprasad, S., Querques, G., Downes, S. M., Fauser, S., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.07.003 · Cited by 478
Dahmana, N., Kowalczuk, L., Gabriel, D., Behar-Cohen, F., Gurny, R., & Kalia, Y. N. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00707 · Cited by 7
Metadata
- Authors
- Zhao, M., Célérier, I., Bousquet, E., Jeanny, J.-C., Jonet, L., Savoldelli, M., Offret, O., Curan, A., Farman, N., Jaisser, F., & Behar-Cohen, F.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-07-02
- Volume
- 122
- Issue
- 7
- Pages
- 2672-2679
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2151703860
- Cited by
- 383
- References
- 36
- FWCI
- 16.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. https://app.cochat.ai/papers/10.1172/jci61427
- The paper
- Zhao, M., Célérier, I., Bousquet, E., Jeanny, J.-C., Jonet, L., Savoldelli, M., Offret, O., Curan, A., Farman, N., Jaisser, F., & Behar-Cohen, F. (2012). Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. Journal of Clinical Investigation. https://doi.org/10.1172/jci61427
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.